The Intravenous Nucleic Acid Therapeutics market was valued at USD 1.60 Billion in 2024 and is expected to reach USD 2.76 Billion by 2032, growing at a CAGR of 7.07% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.